Affordable Access

Publisher Website

Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure

American Journal of Kidney Diseases
Publication Date
DOI: 10.1016/s0272-6386(99)70147-2
  • Apolipoprotein(A)
  • Lipoprotein(A)
  • Chronic Renal Failure
  • Continuous Ambulatory Peritoneal Dialysis
  • Hemodialysis.
  • Biology
  • Medicine


Abstract Patients with renal failure have an increased incidence of atherosclerotic disease. Numerous studies have shown that these patients show increased serum lipoprotein(a) [Lp(a)] concentrations compared with the control population. However, variable alleles at the apolipoprotein(a) [apo(a)] gene locus determine to a large extent the Lp(a) concentration in the general population. We therefore undertook the present study to evaluate apo(a) phenotypes and Lp(a) serum concentrations in a large number of patients with renal disease. Seventy-nine patients treated by hemodialysis (HD), 47 patients treated by continuous ambulatory peritoneal dialysis (CAPD), 68 patients with mild/moderate chronic renal failure (CRF) and serum creatinine levels of 1.8 to 8 mg/dL, and 73 healthy controls were studied. All patients showed significantly elevated median serum Lp(a) concentrations in comparison with controls: HD patients, 15.7 mg/dL ( P < 0.01); CAPD patients, 20 mg/dL ( P < 0.005); CRF patients, 15.1 mg/dL ( P < 0.01) versus controls, 7 mg/dL. The greater Lp(a) values in all groups were not explained by differences in isoform frequencies, whereas their increase was apo(a)-type specific. Thus, patients in all groups with high-molecular-weight (HMW) apo(a) isoforms showed a significant elevation of Lp(a) levels, whereas serum Lp(a) concentrations in patients with low-molecular-weight (LMW) isoforms were not significantly different from controls, except for CAPD patients, who presented increased serum Lp(a) concentrations. We conclude that in patients with renal failure, even of mild/moderate degree, as well as in patients with end-stage renal disease undergoing HD or CAPD, elevated Lp(a) concentrations are mainly observed in those with HMW apo(a) phenotypes.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Apolipoprotein(a) phenotypes and lipoprotein(a) co...

on American journal of kidney dis... June 1999

Lipoprotein(a) serum concentrations and apolipopro...

on Journal of the American Societ... January 2000

Lipoprotein(a) and apolipoprotein(a) phenotypes in...

on Peritoneal dialysis internatio... 1997

Apolipoprotein(a) phenotypes and lipoprotein(a) co...

on Journal of Molecular Medicine January 1995
More articles like this..